Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
6–11
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male and female participants with body mass index (BMI) ≥ the 95th percentile for age and sex
Have failed to achieve adequate weight loss through lifestyle modification in the investigator's opinion
Female participants only: Determined as prepubertal Tanner Stage 1.
You may not be if
Change in body weight above 5 kg (11 lbs) within 90 days before screening irrespective of medical records
Have obesity induced by other endocrinologic disorders (for example, Cushing syndrome) or diagnosed monogenetic or syndromic forms of obesity
Have acute or chronic pancreatitis or a history of acute idiopathic pancreatitis; or have other GI disorders
Have a known clinically significant gastric emptying, have undergone weight loss surgery such as gastric bypass (bariatric) surgery or restrictive bariatric surger, or have endoscopic or device-based therapy for obesity or have had device removal within the last 6 months.
Have confirmed type 1 or type 2 diabetes mellitus
Have a history or current cerebrovascular, respiratory, hepatic, renal, GI, endocrine, hematological, or neurological disorders capable of significantly altering the absorption, metabolism, or elimination of drugs; constituting a risk when taking the IP; or may interfere with the interpretation of data
